Correction: June 29, 2017, 4:00 P.M.: An earlier version of this article mistakenly named Innate Immunotherapeutics as Innate Pharma. (fortune.com)
Career Goals: Developing of novel immunotherapeutic strategies for the treatment of chronic allergic inflammation and airway remodeling. (lji.org)
Peter P. Lee, M.D., the Billy and Audrey L. Wilder Professor in Cancer Immunotherapeutics at City of Hope, has for two decades been interested in treating cancer by stimulating or enhancing a person's own immune system. (cityofhope.org)